ASTRAZENECA AB

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 38942
 
  
 
C07D HETEROCYCLIC COMPOUNDS 22928
 
  
 
A61M DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY 6589
 
  
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 4213
 
  
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 3164
 
  
 
C07C ACYCLIC OR CARBOCYCLIC COMPOUNDS 30108
 
  
 
C07K PEPTIDES 13123
 
  
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 1287
 
  
 
C07F ACYCLIC, CARBOCYCLIC, OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM, OR TELLURIUM 1060
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 10157

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2018/0028,541 CERTAIN (2S)-N-[(1S)-1-CYANO-2-PHENYLETHYL]-1,4-OXAZEPANE-2-CARBOXAMIDES AS DIPEPTIDYL PEPTIDASE 1 INHIBITORS FOR TREATING BRONCHIECTASISJul 28, 17Feb 01, 18[A61K]
2018/0021,359 COMBINATION COMPRISING AN OMEGA-3 FATTY ACID COMPOSITION AND AN SGLT2 INHIBITORAug 09, 17Jan 25, 18[A61K]
2017/0367,988 LIPID NANOPARTICLES COMPRISING LIPOPHILIC ANTI-INFLAMMATORY AGENTS AND METHODS OF USE THEREOFMay 08, 17Dec 28, 17[A61K]
2017/0333,353 BILAYER TABLET FORMULATIONSMar 06, 17Nov 23, 17[A61K]
2017/0319,578 COMPOUNDS AND THEIR USE AS BACE INHIBITORSJul 26, 17Nov 09, 17[A61K, C07D]
2017/0216,283 COMPOUNDS AND USESApr 17, 17Aug 03, 17[A61K]
2017/0165,248 SOLID DOSAGE FORM COMPRISING PROTON PUMP INHIBITOR AND SUSPENSION MADE THEREOFFeb 10, 17Jun 15, 17[A61K]
2017/0135,981 Method for Suppressing Glucagon Secretion of an SGLT2 InhibitorMay 14, 15May 18, 17[A61K]
2017/0106,154 DRY POWDER INHALERMay 13, 15Apr 20, 17[A61M]
2017/0081,325 Imidazo[4,5-c]quinolin-2-one Compounds and Their Use in Treating CancerSep 16, 16Mar 23, 17[A61K, C07D]

View all Publication..

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9918985 Compounds and their use as BACE inhibitorsJul 26, 17Mar 20, 18[A61K, C07D]
9902731 Chemical compoundsNov 08, 16Feb 27, 18[A61K, C07D, A61P]
9890140 Maleate salts of a quinazoline derivative useful as an antiangiogenic agentSep 13, 16Feb 13, 18[A61K, C07D, C07C]
9879017 Processes for the preparation of AZD5363 and intermediate used thereinMay 26, 15Jan 30, 18[C07D]
9873678 Chemical compoundsMar 17, 15Jan 23, 18[A61K, C07D]
9856255 Imidazo[4,5-c]quinolin-2-one compounds and their use in treating cancerSep 16, 16Jan 02, 18[A61K, C07D]
9845331 Chemical compoundsJun 27, 16Dec 19, 17[C07D]
9840518 MCL-1 inhibitors and methods of use thereofApr 21, 17Dec 12, 17[C07D]
9822075 NMDA antagonist prodrugsOct 30, 14Nov 21, 17[A61K, C07D, C07K]
9822111 Imidazo[4,5-c]quinolin-2-one compounds and their use in treating cancerJul 22, 16Nov 21, 17[A61K, C07D]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2017/0198,049 METHODS FOR REDUCING EXACERBATION RATES OF ASTHMA USING BENRALIZUMABAbandonedSep 02, 16Jul 13, 17[C07K]
2017/0107,291 METHODS FOR TREATING CHRONIC OBSTRUCTIVE PULMONARY DISEASE USING BENRALIZUMABAbandonedMay 31, 16Apr 20, 17[C07K]
2016/0317,540 Therapeutic TreatmentAbandonedJul 08, 16Nov 03, 16[A61K]
2016/0184,303 COMPOUNDS AND THEIR USE AS BACE INHIBITORSAbandonedDec 22, 15Jun 30, 16[A61K]
2016/0176,906 Chemical CompoundsAbandonedDec 15, 15Jun 23, 16[C07F, C07D]
2016/0176,912 Novel Ticagrelor Co-CrystalAbandonedJun 29, 15Jun 23, 16[C07H]
2016/0108,049 Novel Phthalazinone-Pyrrolopyrimidinecarboxamide DerivativesAbandonedDec 03, 15Apr 21, 16[C07D]
2016/0060,240 CHROMENONE DERIVATIVESAbandonedApr 08, 15Mar 03, 16[C07D]
2016/0030,574 PHARMACEUTICAL COMPOSITION 271AbandonedOct 15, 15Feb 04, 16[A61K]
2015/0290,179 Oral Dosage Form Containing A PDE 4 Inhibitor as an Active Ingredient and Polyvinylpyrrolidon as ExcipientAbandonedJun 09, 15Oct 15, 15[A61K]
2015/0290,178 Oral Dosage Form Containing A PDE 4 Inhibitor as an Active Ingredient and Polyvinylpyrrolidon as ExcipientAbandonedJun 05, 15Oct 15, 15[A61K]
2015/0290,180 Oral Dosage Form Containing A PDE 4 Inhibitor as an Active Ingredient and Polyvinylpyrrolidon as ExcipientAbandonedJun 09, 15Oct 15, 15[A61K]
2015/0272,955 Triazolo[4,5-D]Pyrimidine Compounds For Treatment Of Abdominal Aortic AneurysmsAbandonedJan 15, 15Oct 01, 15[A61K]
2015/0252,077 Melanocortin Receptor-Specific PeptidesAbandonedMay 21, 15Sep 10, 15[C07K]
2015/0216,861 CYCLOPROPYL AMIDE DERIVATIVESAbandonedApr 13, 15Aug 06, 15[A61K]
2015/0164,889 CYCLOPROPYL AMIDE DERIVATIVESAbandonedFeb 24, 15Jun 18, 15[A61K]
2015/0164,888 CYCLOPROPYL AMIDE DERIVATIVESAbandonedFeb 24, 15Jun 18, 15[A61K]
2015/0141,387 PHARMACEUTICAL PRODUCT COMPRISING A P38 KINASE INHIBITOR AND A SECOND ACTIVE INGREDIENTAbandonedJan 14, 15May 21, 15[A61K]
2015/0104,447 METHODS FOR TREATING CHRONIC OBSTRUCTIVE PULMONARY DISEASE USING BENRALIZUMABAbandonedOct 14, 14Apr 16, 15[C07K]
2015/0079,186 SOLID DOSAGE FORM COMPRISING PROTON PUMP INHIBITOR AND SUSPENSION MADE THEREOFAbandonedDec 03, 14Mar 19, 15[A61K]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.